- Reaction score
- 686
The picture of the mouse (yes i know stupid mice) is the best i have seen so far.
dNovo new promissing player in the stemcell race
- Thread starter byebyehair
- Start date
The picture of the mouse (yes i know stupid mice) is the best i have seen so far.
The guy behind this company is no joke
www.ycombinator.com
dNovo: The cure for hair loss. | Y Combinator
The cure for hair loss. Founded in 2018 by Ernesto Lujan, dNovo has 4 employees based in San Jose, CA, USA.
You can see their company is no joke when their mouse results is better then tsuji and stemson combinedThe guy behind this company is no joke
dNovo: The cure for hair loss. | Y Combinator
The cure for hair loss. Founded in 2018 by Ernesto Lujan, dNovo has 4 employees based in San Jose, CA, USA.
Last edited:
Yeah, the pic looks pretty damn good.
But what excites me the most is that this guy participated and co-published in very important recent studies on stem cell reprogramming. Those that cause a paradigm shift
Hopefully they can start clinical trials soon. Stemson is not going to have it so easy now
Here is one of his most groundbreaking work published to date:
Early reprogramming regulators identified by prospective isolation and mass cytometry - Nature
Identification of transient early induced pluripotency reprogramming intermediates allows for mechanistic insight into the reprogramming process.
www.nature.com
So they were founded in 2018 (same year os Stemson) yet as of today their website is just a one page marketing flyer stuffed with buzzwords with no material info about pretty much anything, like about how much they have raised (very little) or a team page, just some generic claims of having “Stanford, Caltech etc.” scientists working for them.
Am I going to be excited because they in their flyer website a mouse pic in a nice angle (marketing trick), in 2022? No, at least not yet
But even though my hopes are not up I’m cheering for the company and wish them good luck. And hopefully they can start clinical trials soon.
Am I going to be excited because they in their flyer website a mouse pic in a nice angle (marketing trick), in 2022? No, at least not yet
But even though my hopes are not up I’m cheering for the company and wish them good luck. And hopefully they can start clinical trials soon.
Last edited:
- Reaction score
- 686
read about it here. You should check it out. It is a good source for information.
Idk if you're aware or not. Either way this is brilliant
- Reaction score
- 172
everyone knows the most important thing when you are doing biotech research is having a sparkly pop science website much like samumed or replicel who did very solid and successful science. the history of published papers e.g mewns nothing, we presence is what its all about
- Reaction score
- 481
This.
Website with buzzwords in neon blue, no before after pictures and a penny stock listing/5b€ valuation or it ain't worth my time
They went through Y combinator, so they've raised exactly 500k excluding any earlier angel rounds. The founder is under 30 and a duel phd standford/harvard in cellular genetics, so yes they have "Standford scientists working for them". It looks like this company was spun out of his post-doctoral research thesis.
This is the kind of guy that should be trying to cure cancer but instead got entrepreneurial and decided to cure hairloss to get rich, yet you guys would rather whine about how the website looks and about mouse pictures then even take a second to do any research. The website launch probably corresponds with them looking to raise a follow up round of venture funding for trials, so expect that to be announced this year.
Last edited:
Lol, couldnt agree more..
Anyway, i came across with this article. Its really interesting given one of HM companies biggest obstacle to date has been to reliable differenciate dp cells without losing their original hf inducting capabilities.
Researchers identify 'bridge' state necessary for cellular reprogramming
Last edited:
- Reaction score
- 479
Well let's hope for all our follicles sake that this Stanford-entrepreneur doesn't follow in the same footsteps as his alumni and end up with a conviction for criminal conspiracy and wire fraud on his road to getting rich.
Someone should look up the correlation between Stanford scientists and the urge to commit felonies, must be high at this point.
- Reaction score
- 214
Y Combinator funded + exceptionally talented and credible team of executive doesnt mean they will cure your hairloss. But, they definitely know what theyre doing (No shade, but muchhh better than our hairlosstalk geniuses), and it seems like theyve already made substantial contributions to hairloss research. Cant complain about another good company to keep an eye on. Some of yall asking too much 
- Reaction score
- 974
Unfortunately it seems also to be years away
The fact that they have been through YC and probably got some seed funding is good and all (even though AFAIK the YC partners have next to none experience in the biotech sector), but I couldn’t care less about the mouse pic some people are drooling over here.
Cmon people, researchers have been able to grow hair on mice for more than 2 decades now. That pic shouldn’t impress anyone in 2022.
Cmon people, researchers have been able to grow hair on mice for more than 2 decades now. That pic shouldn’t impress anyone in 2022.
Last edited:
Human Hair Stem Cells Generated Using dNovo’s Proprietary Direct Reprogramming Technology (Patent-Pending)
Our first objective was to generate personalized hair stem cells using our direct reprogramming technology. In 2019, we were successful in putting together our direct reprogramming system to generate human hair stem cells (patent pending). These reprogrammed human cells successfully reactivated the genetic circuitry of native hair stem cells. They also performed biochemically as expected of native hair stem cells. After demonstrating this breakthrough, we sought to validate the functionality of our newly reprogrammed human hair stem cells.
Human Dermal Papilla Cells Generated Using dNovo’s Proprietary Direct Reprogramming Technology (Patent-Pending)
Dermal papilla cells are another important component of the hair follicle. These cells serve as the signaling center for hair stem cells and promote robust hair growth. In certain cases where the entire hair follicle is depleted, dermal papilla cells are also lost, and so we sought to generate these cells with our direct reprogramming technology. We have now successfully developed the reprogramming system to generate these human dermal papilla cells (patent pending). Our reprogrammed dermal papilla cells successfully reactivate the native genetic circuitry and perform biochemically as expected of human dermal papilla cells.
So, they have 2 patents. How long it will take to approve patents to some biomedical company? Like I see they are waiting to approve their patent from Q3 2019.
Our first objective was to generate personalized hair stem cells using our direct reprogramming technology. In 2019, we were successful in putting together our direct reprogramming system to generate human hair stem cells (patent pending). These reprogrammed human cells successfully reactivated the genetic circuitry of native hair stem cells. They also performed biochemically as expected of native hair stem cells. After demonstrating this breakthrough, we sought to validate the functionality of our newly reprogrammed human hair stem cells.
Human Dermal Papilla Cells Generated Using dNovo’s Proprietary Direct Reprogramming Technology (Patent-Pending)
Dermal papilla cells are another important component of the hair follicle. These cells serve as the signaling center for hair stem cells and promote robust hair growth. In certain cases where the entire hair follicle is depleted, dermal papilla cells are also lost, and so we sought to generate these cells with our direct reprogramming technology. We have now successfully developed the reprogramming system to generate these human dermal papilla cells (patent pending). Our reprogrammed dermal papilla cells successfully reactivate the native genetic circuitry and perform biochemically as expected of human dermal papilla cells.
So, they have 2 patents. How long it will take to approve patents to some biomedical company? Like I see they are waiting to approve their patent from Q3 2019.